Back to search
FDAFDA · Food and drugs·Recall number D-0061-2018

HYDROmorphone HCl 20 mcg / mL BUPIvacaine HCl 0.075% in 0.9% Sodium Chloride 50 mL (HYDROmorphone Total Dose 1000 mcg) Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205, NDC 70004-0331-22

Published November 8, 2017 · Recall initiated: October 19, 2017

Summary

FDA records drug Class II recall D-0061-2018, published November 8, 2017 and initiated October 19, 2017. Recalling firm: SCA Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 60 bags; Lot: Lot: 20170816@65 BUD: 10/30/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack Of Assurance Of Sterility.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals, LLC
Distributor
Nationwide in the United States
Lot
Lot: 20170816@65 BUD: 10/30/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was HYDROmorphone HCl 20 mcg / mL BUPIvacaine HCl 0.075% in 0.9% Sodium Chloride 50 mL (HYDROmorphone Total Dose 1000 mcg) Rx Only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205, NDC 70004-0331-22 recalled?

Yes. FDA published recall D-0061-2018 on November 8, 2017. Reported hazard: Lack Of Assurance Of Sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter